Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Sep 7, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | $688.27B | 0.59% | 36.50% | $1.5000 | $4.30 | 12% | 0 | 2025-09-10 | |
| RYAAY | RYANAIR HOLDINGS PLC | $32.19B | 0.64% | 37.50% | $0.3852 | $0.39 | 14% | 1 | 2025-09-12 | 2025-09-25 |
| WIX | WIXCOM LTD | $8.56B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BGC | BGC GROUP INC | $4.71B | 0.80% | 25.80% | $0.0200 | $0.08 | 18% | 2 | ||
| IHS | IHS HOLDING LTD | $2.44B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DBD | DIEBOLD NIXDORF INC | $2.19B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FIVN | FIVE9 INC | $2.06B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARDT | ARDENT HEALTH PARTNERS INC | $1.88B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NTCT | NETSCOUT SYSTEMS INC | $1.77B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.74B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AVDL | AVADEL PHARMACEUTICALS PLC | $1.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GBX | GREENBRIER COMPANIES INC | $1.46B | 2.63% | 16.60% | $0.3200 | $1.24 | 58% | 0 | ||
| DCO | DUCOMMUN INC | $1.35B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LMB | LIMBACH HOLDINGS INC | $1.25B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EVER | EVERQUOTE INC | $859.51M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NRDS | NERDWALLET INC | $795.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AKBA | AKEBIA THERAPEUTICS INC | $777.40M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TBPH | THERAVANCE BIOPHARMA INC | $702.54M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KMDA | KAMADA LTD | $410.59M | 2.80% | 60.60% | $0.2000 | $0.20 | 61% | 0 | ||
| ELMD | ELECTROMED INC | $204.30M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.